We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
(+12%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
28.27%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$96.9M |
| 2 |
Merck
MRK
|
+$73.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$57.1M |
| 4 |
Illumina
ILMN
|
+$40.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$57.2M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$51.7M |
| 3 |
Kimberly-Clark
KMB
|
+$28.5M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$26.5M |
| 5 |
Arista Networks
ANET
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.77% |
| 2 | Technology | 20.35% |
| 3 | Consumer Discretionary | 9.49% |
| 4 | Communication Services | 7.69% |
| 5 | Financials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Loop Industries
LOOP
$34.8M
| $1.49M | 0.01% |
108,895
+20,870
| +24% | +$225K |
|
527
TotalEnergies
TTE
$193B
| $1.47M | 0.01% |
42,740
-25,073
| -37% | -$955K |
|
528
Apollo Global Management
APO
$69B
| $1.41M | 0.01% |
31,575
+3,100
| +11% | +$149K |
|
529
Shopify
SHOP
$168B
| $1.41M | 0.01% |
13,780
-380
| -3% | -$37.8K |
|
530
Hormel Foods
HRL
$14.2B
| $1.4M | 0.01% |
28,707
| – | – |
|
531
Brookfield Renewable
BEP
$9.6B
| $1.4M | 0.01% |
39,944
-1,983
| -5% | -$58.6K |
|
532
Jones Lang LaSalle
JLL
$15.8B
| $1.4M | 0.01% |
14,627
-38,256
| -72% | -$3.85M |
|
|
MDRX
533
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.38M | 0.01% |
170,000
+95,000
| +127% | +$776K |
|
534
Northern Trust
NTRS
$21.8B
| $1.38M | 0.01% |
17,651
| – | – |
|
535
Reinsurance Group of America
RGA
$15.5B
| $1.37M | 0.01% |
14,404
-35,479
| -71% | -$3.19M |
|
536
Synchrony
SYF
$24.4B
| $1.37M | 0.01% |
52,207
-5,215
| -9% | -$127K |
|
537
Brookfield
BN
$102B
| $1.35M | 0.01% |
76,494
-2,967
| -4% | -$53K |
|
538
Kraft Heinz
KHC
$32.8B
| $1.35M | 0.01% |
45,084
-1,620
| -3% | -$53.9K |
|
539
Ventas
VTR
$47.5B
| $1.34M | 0.01% |
31,917
-2,457
| -7% | -$98.2K |
|
540
Bank of Montreal
BMO
$123B
| $1.34M | 0.01% |
22,950
| – | – |
|
541
Essential Utilities
WTRG
$11.5B
| $1.33M | 0.01% |
32,941
+124
| +0.4% | +$5.33K |
|
542
Waters Corp
WAT
$37.3B
| $1.32M | 0.01% |
6,769
-1,194
| -15% | -$248K |
|
543
UGI
UGI
$7.87B
| $1.32M | 0.01% |
40,124
-792
| -2% | -$26.3K |
|
|
MR
544
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.31M | 0.01% |
+297,448
| New | +$1.38M |
|
545
BioLife Solutions
BLFS
$1.54B
| $1.3M | 0.01% |
45,000
-31,000
| -41% | -$670K |
|
546
Magna International
MGA
$18.8B
| $1.3M | 0.01% |
28,472
+19,594
| +221% | +$943K |
|
547
Hewlett Packard
HPE
$58.8B
| $1.29M | 0.01% |
137,747
+1,012
| +0.7% | +$9.66K |
|
548
Uber
UBER
$145B
| $1.29M | 0.01% |
35,381
-1,000
| -3% | -$33K |
|
549
Match Group
MTCH
$9.19B
| $1.29M | 0.01% |
+11,663
| New | +$1.24M |
|
550
NeoGenomics
NEO
$1.96B
| $1.29M | 0.01% |
34,983
-527,115
| -94% | -$19.6M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2020 Portfolio in Review
As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.
- Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
- Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
- Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
- Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
- Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
- Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
- Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.
Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.